1.
What is The Comparative Effectiveness of Targeted Therapy versus Immunotherapy in Terms of Overall Survival, Progression-free Survival, and Quality of Life For Patients With Metastatic Renal Cell Carcinoma? : A Systematic Review and Meta-Analysis . JOC. 2025;24(10s):274-299. doi:10.64149/J.Carcinog.24.10s.274-299